| Reg. číslo | Kód | Liek / Účinná látka | Doplnok | Držiteľ |
|---|---|---|---|---|
| 18/0224/21-S | 8349D | Vimetso 50 mg/850 mg filmom obalené tablety | tbl flm 120(2x60)x50 mg/850 mg (blis.OPA/Al/PVC/Al - multibal.) | KRK-2 |
| 18/0224/21-S | 8347D | Vimetso 50 mg/850 mg filmom obalené tablety | tbl flm 120x50 mg/850 mg (blis.OPA/Al/PVC/Al) | KRK-2 |
| 18/0224/21-S | 8344D | Vimetso 50 mg/850 mg filmom obalené tablety | tbl flm 10x50 mg/850 mg (blis.OPA/Al/PVC/Al) | KRK-2 |
| 58/0024/22-S | 9541D | Co-Prenessa Neo 10 mg/2,5 mg tablety | tbl 100x10 mg/2,5 mg (blis.OPA/Al/PVC//Al) | KRK-2 |
| 58/0024/22-S | 9537D | Co-Prenessa Neo 10 mg/2,5 mg tablety | tbl 10x10 mg/2,5 mg (blis.OPA/Al/PVC//Al) | KRK-2 |
| 58/0023/22-S | 9536D | Co-Prenessa Neo 5 mg/1,25 mg tablety | tbl 100x5 mg/1,25 mg (blis.OPA/Al/PVC//Al) | KRK-2 |
| 58/0023/22-S | 9534D | Co-Prenessa Neo 5 mg/1,25 mg tablety | tbl 60x5 mg/1,25 mg (blis.OPA/Al/PVC//Al) | KRK-2 |
| 65/0215/21-S | 8198D | Apeneta 250 mg tablety s predĺženým uvoľňovaním | tbl plg 100x250 mg (fľ.HDPE) | KRK-2 |